Literature DB >> 16982160

Protection in alpacas against Corynebacterium pseudotuberculosis using different bacterial components.

Walter U Braga1.   

Abstract

Corynebacterium pseudotuberculosis is a Gram positive bacterium that produces caseous lymphadenitis in sheep and goats, and a granulomatous lymphadenitis in llamas and alpacas. To evaluate the immune potential of different doses of cell wall and toxin components of C. pseudotuberculosis from alpaca origin, 12 adult alpacas were allotted at random to four groups, and SC inoculated in the left flank with vaccines composed of low and high doses of bacterial crude antigens, cell wall: 250 and 500 microg/ml and toxin: 133 and 265 microg/ml, respectively. The vaccines were supplemented with 20 microg/ml of muramyl dipeptide as adjuvant. Three alpacas were sham inoculated with adjuvant as a control. After 3 weeks, immunized and naive alpacas were challenged intradermally in the right flank with 1 x 10(6) colony forming units (CFU) of C. pseudotuberculosis. The alpacas were sacrificed at days 28, 58 and 112 after inoculation, and the degree of protection induced by vaccines was demonstrated by the absence of abscesses and/or bacteria. The alpacas vaccinated with high dose of toxin, did not show abscesses. In contrast, the alpacas vaccinated with a low dose of toxin showed abscesses at the inoculation site, regional, and renal lymph nodes. The cell wall vaccinated alpacas showed a lesser degree of protection than the other groups with superficial and internal abscesses. The control alpacas had persistent fever and abscesses at the inoculation site, regional, and internal lymph nodes. In addition, a robust and early humoral response was observed in all vaccinated alpacas after challenge, lasting at least 3 months. The results suggest that the toxin of C. pseudotuberculosis is a very important antigen, inducing a dose dependant protective immunity against this bacterium in alpacas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982160     DOI: 10.1016/j.vetmic.2006.08.019

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  6 in total

1.  Complete genome sequence of Corynebacterium pseudotuberculosis strain Cp267, isolated from a llama.

Authors:  Thiago Lopes; Artur Silva; Rommel Thiago; Adriana Carneiro; Fernanda Alves Dorella; Flavia Souza Rocha; Anderson Rodrigues dos Santos; Alex Ranieri Jerônimo Lima; Luis Carlos Guimarães; Eudes G V Barbosa; Dayana Ribeiro; Karina Kelly Fiaux; Carlos Augusto Almeida Diniz; Vinicius Augusto Carvalho de Abreu; Sintia Silva de Almeida; Syed Shah Hassan; Amjad Ali; Syeda Marriam Bakhtiar; Flávia Figueira Aburjaile; Anne Cybelle Pinto; Siomar de Castro Soares; Ulisses de Padua Pereira; Maria Paula C Schneider; Anderson Miyoshi; Judy Edman; Sharon Spier; Vasco Azevedo
Journal:  J Bacteriol       Date:  2012-07       Impact factor: 3.490

2.  Corynebacterium pseudotuberculosis liver abscess in a mature alpaca (Lama pacos).

Authors:  Philippa Sprake; Jenifer R Gold
Journal:  Can Vet J       Date:  2012-04       Impact factor: 1.008

Review 3.  Vaccines for caseous lymphadenitis: up-to-date and forward-looking strategies.

Authors:  Rodrigo Barros de Pinho; Mara Thais de Oliveira Silva; Francisco Silvestre Brilhante Bezerra; Sibele Borsuk
Journal:  Appl Microbiol Biotechnol       Date:  2021-03-02       Impact factor: 4.813

4.  Cytopathological and bacteriological studies on caseous lymphadenitis in cattle slaughtered at Bishoftu municipal abattoir, Ethiopia.

Authors:  Mesfin Mathewos; Haben Fesseha
Journal:  Vet Med Sci       Date:  2022-02-04

5.  Corynebacterium pseudotuberculosis Infections in Alpacas (Vicugna pacos).

Authors:  Reinhard Sting; Claudia Geiger; Wolfram Rietschel; Birgit Blazey; Ingo Schwabe; Jörg Rau; Lisa Schneider-Bühl
Journal:  Animals (Basel)       Date:  2022-06-22       Impact factor: 3.231

6.  Frequency of caseous lymphadenitis (CLA) in sheep slaughtered in an abattoir in Tabriz: comparison of bacterial culture and pathological study.

Authors:  Fereydon Rezazadeh Zavoshti; Amir Babak Sioofy Khoojine; Javad Ashrafi Helan; Belal Hassanzadeh; Ali Akbar Heydari
Journal:  Comp Clin Path       Date:  2011-01-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.